CASI Pharmaceuticals, Inc. (CASI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 31.36M |
| Enterprise value | 21.83M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.92 |
| Price/book (mrq) | 1.30 |
| Enterprise value/revenue | 0.64 |
| Enterprise value/EBITDA | -1.01 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.33 |
| 52-week change 3 | -13.01% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 8.4800 |
| 52-week low 3 | 1.8500 |
| 50-day moving average 3 | 3.7480 |
| 200-day moving average 3 | 4.0847 |
Share statistics
| Avg vol (3-month) 3 | 201.18k |
| Avg vol (10-day) 3 | 24.38k |
| Shares outstanding 5 | 13.4M |
| Implied shares outstanding 6 | 13.4M |
| Float 8 | 5.44M |
| % held by insiders 1 | 47.45% |
| % held by institutions 1 | 8.45% |
| Shares short (15 Apr 2024) 4 | 62.51k |
| Short ratio (15 Apr 2024) 4 | 0.87 |
| Short % of float (15 Apr 2024) 4 | 0.71% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.47% |
| Shares short (prior month 15 Mar 2024) 4 | 127.33k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 02 Jun 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -79.51% |
| Operating margin (ttm) | -50.32% |
Management effectiveness
| Return on assets (ttm) | -18.42% |
| Return on equity (ttm) | -57.65% |
Income statement
| Revenue (ttm) | 33.88M |
| Revenue per share (ttm) | 2.54 |
| Quarterly revenue growth (yoy) | -55.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -21.54M |
| Net income avi to common (ttm) | -26.96M |
| Diluted EPS (ttm) | -2.0200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 30.77M |
| Total cash per share (mrq) | 2.37 |
| Total debt (mrq) | 21.24M |
| Total debt/equity (mrq) | 87.89% |
| Current ratio (mrq) | 3.55 |
| Book value per share (mrq) | 1.81 |
Cash flow statement
| Operating cash flow (ttm) | -19.97M |
| Levered free cash flow (ttm) | -13.71M |
© 2024 Yahoo. All rights reserved.